Impact of Skipping Hemoglobin A1c Testing During Coronavirus Disease-2019 Pandemic |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.18, No. 2)Publication Date: 2023-03-07
Authors : Harvey W Kaufman MD; Ky Van MS; Michael McPhaul MD;
Page : 206-207
Keywords : Hemoglobin A1c; Diabetes; COVID-19; Pandemic; Missed care;
Abstract
During the COVID-19 pandemic many patients skipped care. In this study of 2,411,751 patients in the United States, patients who skipped hemoglobin A1c testing in 2020 were adversely affected based on hemoglobin A1c values, compared to patients who did not skip testing in 2020.
Other Latest Articles
- Concepts and Prospects of Social Health Insurance in Nigeria |Biomedgrid
- Requirements for a Vision Based System for Detecting Epileptic Seizures |Biomedgrid
- TREATMENT OF TRAUMATIC AMELOGENESIS IMPERFECTA THROUGH MICRO-ABRASION TECHNIQUE: A CASE REPORT
- EXTRAVASATION DES PRODUITS DE CHIMIOTHERAPIE : UNE APPROCHE CRUCIALE DU SERVICE DE LA CHIRURGIE PLASTIQUE DE MARRAKECH
- THE BENEFITS OF PLASTIC AND RECONSTRUCTIVE SURGERY IN THE MANAGEMENT OF AN EAR HAMARTOMA
Last modified: 2024-09-24 22:10:35